← Back to Search

Procedure

DBS of VIM and PSA for Essential Tremor

N/A
Waitlist Available
Led By Sana Aslam, DO
Research Sponsored by St. Joseph's Hospital and Medical Center, Phoenix
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up following two weeks of treatment at each intervention
Awards & highlights

Study Summary

This trial will study whether stimulating two areas of the brain at once is more effective in treating essential tremor than stimulating just one area.

Eligible Conditions
  • Essential Tremor

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~following two weeks of treatment at each intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and following two weeks of treatment at each intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Stimulation-Induced Balance
Change in Stimulation-Induced Dysarthria
Change in Tremor Phenomenology
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Group 3Experimental Treatment3 Interventions
Subjects will receive PSA stimulation for two weeks, followed by VIM stimulation for two weeks, and finally VIM+PSA stimulation for two weeks.
Group II: Group 2Experimental Treatment3 Interventions
Subjects will receive VIM+PSA stimulation for two weeks, followed by PSA stimulation for two weeks, and finally VIM stimulation for two weeks.
Group III: Group 1Experimental Treatment3 Interventions
Subjects will receive VIM stimulation for two weeks, followed by VIM+PSA stimulation for two weeks, and finally PSA stimulation for two weeks.

Find a Location

Who is running the clinical trial?

St. Joseph's Hospital and Medical Center, PhoenixLead Sponsor
64 Previous Clinical Trials
14,646 Total Patients Enrolled
2 Trials studying Essential Tremor
5,000 Patients Enrolled for Essential Tremor
Sana Aslam, DOPrincipal InvestigatorSt Josephs Hospital and Medical Center
1 Previous Clinical Trials
11 Total Patients Enrolled

Media Library

PSA Stimulation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05096572 — N/A
Essential Tremor Research Study Groups: Group 3, Group 2, Group 1
Essential Tremor Clinical Trial 2023: PSA Stimulation Highlights & Side Effects. Trial Name: NCT05096572 — N/A
PSA Stimulation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05096572 — N/A
~0 spots leftby Jun 2025